Results 201 to 210 of about 7,232 (251)

Midodrine

Reactions Weekly
S. Midodrine
semanticscholar   +11 more sources

Midodrine

American Journal of Therapeutics, 2019
Nikhil Cordeiro, Sushilkumar Satish Gupta, Daniel Lindsay, Chanaka Seneviratne, Guy Kulbak, Yizhak Kupfer   +5 more
  +7 more sources

Abstract TAC151: Midodrine Under Pressure; Managing Hypotension In Heart Failure With Reduced Ejection Fraction: Real-World Propensity Matched Data Reveals Conflicting Signals In Long-Term Risk

HYPERTENSION
Background: Midodrine is often used off-label to manage hypotension in patients with heart failure with reduced ejection fraction (HFrEF), but its long-term safety and clinical impact remain unclear. This study evaluated real-world outcomes associated
Rayan Salih, Leina Elomeiri, Sana Ahmed, Sheena Bhushan, Oluwafemi Olukayode, Riaz Mahmood, Phillip Gross, Idopise Umana, U. Egolum   +8 more
semanticscholar   +1 more source

Efficacy of adjuvant use of midodrine in patients with septic shock: An open label randomized controlled trial

Pharmacotherapy
Midodrine has been primarily studied as an adjunctive oral therapy to reduce the need for vasopressors in intensive care units (ICU). Nonetheless, the available results evaluating midodrine as an adjuvant therapy in the treatment of septic shock are ...
Nadine K El-Nagdy, N. Mansour, Adel Al-Hady Ahmed Diab, Moetaza M. Soliman   +3 more
semanticscholar   +1 more source

MIDODRINE as Adjunct for Septic Shock Requiring Low Dose Vasopressor in ICU

Online Journal of Clinical and Medical Case Reports
Background In septic shock requiring low dose vasopressor (norepinephrine ≤ 10 mcg/min) for more than 24 hours discharge from ICU and hospital is delayed. Midodrine an oral alpha-1 adrenergic agonist is useful in such clinical scenario.
Smita  Sharma
semanticscholar   +1 more source

Midodrine exposure trends and outcomes reported to United States poison centers: 2000–2023

Clinical toxicology
Introduction Midodrine is an oral alpha-1 adrenergic agonist used to treat orthostatic hypotension. Its vasoconstrictive properties can lead to hypertension and reflex bradycardia.
David Kuai, Daniel P Nogee, Stephanie Kieszak, Andrew I Geller, Michael Yeh, Amy H. Schnall   +5 more
semanticscholar   +1 more source

Use of midodrine to discontinue intravenous vasopressors in intensive care unit patients

The Southwest Journal of Medicine
Purpose: Midodrine, an oral alpha-adrenergic agonist, has been used off-label in critically ill patients to facilitate discontinuation of intravenous (IV) vasopressors.
Akash Dev, Ana Oliver, Anuya Alapati, Kenneth Nugent   +3 more
semanticscholar   +1 more source

Assessment of Midodrine Initiation and Vasopressor Liberation in Patients With Septic Shock in a Community-Teaching Hospital.

Journal of pharmacy and practice
Purpose: In observational trials, midodrine decreased vasopressor duration, length of stay (LOS), and mortality but not in randomized controlled trials.
Joel Kennedy, Alyssa Osmonson, J. Starr, Sarah B. Blackwell   +3 more
semanticscholar   +1 more source

Use of midodrine for treatment of hypotension: a case report

Turkish Journal of Intensive Care
Midodrine is an orally approved α-agonist increasingly utilized in intensive care units for the treatment of refractory hypotension with peripheral effects.
Zeynep Öztürk Yalçın, B. Halaçlı, Kutay Demirkan, A. Topeli   +3 more
semanticscholar   +1 more source